Docetaxel in Treating Patients With Metastatic Breast Cancer

Completed · Phase 3

Conditions studied: Breast Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase III trial to determine the effectiveness of docetaxel in treating patients who have metastatic breast cancer.

Key facts

Study ID

NCT00008411

Run by

M.D. Anderson Cancer Center

People needed

90

Starts

1999-12-01

Expected to finish

2007-01-01

Last updated by the study team

2012-07-30

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• MD Anderson Cancer Center at University of Texas — Houston, Texas, United States
• University of Texas M.D. Anderson CCOP Research Base — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.